New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

New platform for cancer patient education and support

Hot chemo' offers new treatment option

First UK patients receive experimental mRNA therapy for cancer, Imperial News

New breast cancer treatment could help thousands of women - as it 'slashes risk of disease returning by a quarter

Drug Combination Restores Ability of Leading Treatment to Signal for Death of Blood Cancer Cells

Cancer Causes, Symptoms, Diagnosis, Treatment, and More

Cancer and its treatment could impact survivors' ability to work, says national report

It's not just chemotherapy, there are less toxic tools to fight cancer

For some cancer patients, precision medicine offers hope – and possibility of financial ruin

Taking Supplements During Breast Cancer Treatment Increases Risk Of Death And Relapse, What Does This Mean For Patients?

Clinical update, Cancer Nursing Practice

i.guim.co.uk/img/media/58dccb84b5280f4698e629bef42